Patent · US Active

Pyridone derivates with MCH antagonistic activity and medicaments comprising these compounds

US8067590B2 · kind B2 · utility

9Cited by

0References

12Claims

0Family size

Assignee

Boehringer Ingelheim International GmbH · DE

Inventors

Dirk Stenkamp · Biberach, DE
Stephan Georg Mueller · Warthausen, DE
Gerald Juergen Roth · Biberach, DE
Joerg Kley · Mittelbiberach, DE
Klaus Rudolf · Warthausen, DE
Armin Heckel · Biberach an der Riß, DE
Marcus Schindler · Schwäbisch Hall, DE
Ralf Lotz · Schemmerhofen, DE
Thorsten Lehmann-Lintz · Ochsenhausen, DE

Key dates

Filing date	Aug 24, 2007
Grant date	Nov 29, 2011
Priority date	—
Expiry date	Mar 12, 2030

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D513/04
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to compounds of general formula Iwherein the groups and radicals B, k, L, U, V, W, X, Y, Z, R1, R2, have the meanings given in claim 1. Moreover the invention relates to pharmaceutical compositions containing at least one compound according to the invention. By virtue of their MCH-receptor antagonistic activity the pharmaceutical compositions according to the invention are suitable for the treatment of metabolic disorders and/or eating disorders, particularly obesity, bulimia, anorexia, hyperphagia and diabetes.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.